| Dr Michael Goldstein, MD | |
|
501 Bath Rd, 3rd Floor, Bristol, PA 19007-3101 | |
| (215) 785-9799 | |
| (215) 785-9193 |
| Full Name | Dr Michael Goldstein |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 501 Bath Rd, Bristol, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144363839 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | MD045418L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Goldstein, MD 501 Bath Rd, 3rd Floor, Bristol, PA 19007-3101 Ph: (215) 785-9799 | Dr Michael Goldstein, MD 501 Bath Rd, 3rd Floor, Bristol, PA 19007-3101 Ph: (215) 785-9799 |
News Archive
A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies.
The New York Times: British Company Is Awarded Contract To Administer Health Rollout
A multidisciplinary team from the University of Toronto, with experts from the Faculty of Dentistry and the Waakebiness-Bryce Institute for Indigenous Health at the Dalla Lana School of Public Health have been awarded a five year, $1.5 million grant from the Canadian Institutes of Health Research to study the impact of cannabis use on the oral health of Indigenous populations.
A national survey of recent hospital patients commissioned by TransUnion found that two-thirds of adults nationwide would like to see greater transparency in their hospital bill while only three in 10 of those surveyed were aware they could possibly qualify for charity care programs.
Neurologix, Inc. today announced that a landmark paper, published on October 20th in Science Translational Medicine demonstrating the importance of the p11 gene in modulating depression in mice, utilized a gene therapy approach to reverse depression in mice for which the Company holds exclusive development rights. Based on the findings reported in the paper, gene therapy may have potential as a new treatment option for people who suffer from severe depression.
› Verified 4 days ago
Dr. Lehien Bui, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 501 Bath Rd, 3rd Floor, Bristol, PA 19007 Phone: 215-785-9799 Fax: 215-785-9193 | |
Dr. Augusto Adrid, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 501 Bath Rd, 3rd Floor, Bristol, PA 19007 Phone: 215-785-9799 Fax: 215-785-9193 |